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Introduction
Studies of neuronal stem cells have intensified over the 
past few decades because of the relevance of these cells to the 
treatment of neurodegenerative diseases such as Parkinsons 
or Alzheimers diseases. The hope of better understanding the 
detailed mechanisms of development of the vertebrate nervous 
system, and the potential discovery of long-term treatments 
for neurodegenerative diseases has drawn the interest of many 
scientists. The recent derivations of pluripotent stem cells 
from fully differentiated cells suggest that even “personalized” 
stem cells may be available for gene therapy approaches in the 
future.1, 2
Stem cells are not the only cells known to be pluripotent. 
Embryonic carcinoma cells, like stem cells, have been known 
for some time to be another pluripotent type of cell, isolated 
from murine teratocarcinomas.3 Teratocarcinomas are malig-
nant tumors consisting of different tissue types.  These tumors 
could develop in early mouse embryos that are transplanted 
from the uterus to ectopic sites.4 Cell lines derived from 
teratocarcinoma have many advantages including their ease of 
culture and selection.
P19 Embryonic Carcinoma as a model for developmental 
neurobiology studies 
The P19 line of embryonic carcinoma cells was originally 
derived from a teratocarcinoma formed following the trans-
plantation of a 7.5 day-old embryo into mouse testis.5 The 
primary tumor of the teratocarcinoma was used to establish 
undifferentiated stem cells.6 P19, a specific line of this embry-
onic carcinoma has been long known to be remarkably stable, 
with the requirement that they are maintained in exponential 
growth.6 These cells possess a euploid male karyotype,5 and 
were found to grow continuously in serum-supplemented 
media.6 
Early research with the P19 line aimed to induce differenti-
ation in the cells. Retinoic acid (RA) and DMSO were eventu-
ally found to be the two main agents that successfully induced 
differentiation in P19 cells at non-toxic concentrations.7 For 
studies pertaining to neuronal development, RA became the 
choice inducing reagent.
 RA was found to produce neuroectoderm-based cell types: 
neurons and glia.3 Even maturation of  oligodendrocytes spe-
cifically occurs under conditions where normal myelination 
occurs. Development of oligodendrocytes from RA-treated 
P19 has only been found in neonatal rat brain.6, 8 In contrast to 
RA, DMSO has been found to induce non-neuronal cell types. 
Mesodermal and endodermal cells, especially cardiac and 
skeletal muscle have been easily identified in DMSO-induced 
P19 cells.5, 9 
Interestingly, RA and DMSO induce differentiation via 
different cellular targets, perhaps suggestive of RA and 
DMSO’s specific abilities to induce differentiation of different 
cell types. Mutants have been selected that fail in response to 
one drug and normally differentiate in response to the other.9 
For example, a P19 cell line designated D3 was incapable 
of muscle development, but was found to differentiate into 
neurons and glial cells in response to high concentrations of 
RA. Within six days of initial RA exposure, up to 85% of the 
cells expressed markers like tetanus toxin binding sites, which 
are characteristically found in neuronal cells.7, 10 Non-neuronal 
cells placed in the same cultures did not bind tetanus toxin.11
Following RA application, the fraction of P19-derived 
neuronal cells declined with time after six days, due to the 
neurons being post-mitotic, and with non-neuronal cells 
continuing to proliferate.6 Survival of the neuronal cells is 
seemingly dependent on whether or not non-neuronal cells or 
growth factors are present.6, 12 
In vivo studies of P19 embryonic carcinoma cell differentia-
tion
In vivo survival of P19-derived neurons has been studied 
previously, and P19-derived neurons that are placed into a 
natural anatomical setting have been observed to survive 
long-term. When transplanted into the mammalian CNS, 
P19-derived neurons not only survive, but differentiate into 
morphologically and electrophysiologically mature neurons.13 
RA pre-treated P19 cells that have been grafted into the stria-
tum of an immunosuppressed mouse (whose striatial neurons 
have been eliminated with an excitatory neurotoxin) survived 
at least 13 weeks.6
P19-derived neurons have also been shown to have elec-
trophysiological activity. Action potentials were induced in 
these RA-treated P19 grafts by membrane depolarization, 
with evidence suggesting the presence of voltage-dependent 
sodium and potassium channels.6 In older grafts, both depolar-
izing and hyperpolarizing events were observed.14 Synaptic 
potentials in younger grafts were exclusively depolarizing.14 
These observations suggested P19-derived neurons possess 
similar neuronal properties to those of neurons in the develop-
ing forebrain.
Furthermore, P19 neurons have shown early responsive-
ness to basic neurotransmission. Initial studies of RA-treated 
P19 revealed the presence of the neurotransmitters acetyl-
choline and catecholamine as well as the enzymes tyrosine 
hydroxylase, dopamine beta-hydroxylase and phenyletha-
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nolamine N-methyltransferase.15 Low levels of histofluores-
cence for endogenous catecholamines were found in these 
neurons.15 Further research has revealed that about 60% of 
these neurons contain GABA, 20% somatostatin, 20% neuro-
peptide Y.6, 16 Tyrosine hydroxylase, DOPA decarboxylase, se-
rotonin, calcitonin gene-related peptide, galanin and substance 
P have also been found in these cells, but at low levels.16
Brain slices of grafted RA-treated P19 cells have revealed 
neurotransmission in vivo. Brains implanted with RA-treated 
P19 cells, within two weeks, had neurons that had developed 
responsiveness to the excitatory neurotransmitter glutamate 
and the inhibitory neurotransmitters gamma-aminobutyric 
acid (GABA) and glycine. Pharmacological studies suggested 
the presence GABAA, NMDA and non-NMDA glutamate 
receptors.14 
In vitro studies of RA-induced P19 cells
In vitro models of P19-derived neuronal activity were 
more recently discovered. The inhibitory neurotransmitter 
GABA was detected in RA-stimulated P19 cells in culture, 
co-localizing with glutamate in some neuron processes.17 
These neurons, when depolarized, responded by releasing 
both GABA and glutamate and the same neurons have been 
identified to express the glutamate receptor subunits GluR1, 
GluR4 and NMDAR1.17 Thus, P19-derived neurons were 
found to mature in culture and form electrically active neural 
networks involving glutamate and glutamate receptors. The 
research implications of a P19-derived neuron in vitro model 
were significant because use of the cell line would allow large 
amounts of homogenous material for studies of neurogenesis 
and synaptogenesis.
P19 cells have also been a model of choice due to the ease 
of genetically manipulating the cells, making them very useful 
for investigating molecular mechanisms concerning neuronal 
differentiation.6 With RA having been the model drug used 
to study P19 neuronal differentiation and properties for many 
years, recent studies have revealed that with RA induction, 
increased expression of neurogenic basic helix-loop-helix 
(bHLH) transcription factors expression has been observed.18 
Basic helix-loop-helix transcription factors are proteins with a 
structural motif characterized by two alpha helices connected 
by a loop. These bHLH proteins are dimeric, with each helix 
containing basic amino acid residues that facilitate DNA bind-
ing.
MASH1 as a transcriptional activator of neuronal differentia-
tion
A particular bHLH transcription factor of interest in recent 
years has been MASH1 (also called ASCl1). MASH1 is a 
mammalian homologue of the Drosophila neural determina-
tion gene achate-scute complex-like 1. Research suggests that 
murine P19 cells are a good model system to study this gene.19 
Studies have also shown that MASH1 is expressed in distinct 
subsets or areas of cells that give rise to only neurons.20 This 
conclusion was made based on studies on the mammalian 
homologue of BarH (MBH1). When expression was analyzed 
MBH1 revealed a complementary pattern to MASH1 expres-
sion in the developing nervous system. Forced expression 
of MBH1 down-regulated MASH1. This suggested MBH1’s 
role as a potential regular of mammalian bHLH genes, and 
reinforced MASH1’s important role in 00……neuronal dif-
ferentiation.20
It was recently discovered in the Turner laboratory at the 
University of Michigan that overexpression of MASH1 alone 
could induce neuronal differentiation.  Prior to these studies, 
MASH1 was known to be required for neuronal differentiation 
in RA-induced P19 cells. Studies in 1993 revealed that dif-
ferentiation of P19 cells into neuronal cell types by exposure 
to retinoic acid resulted in the induction of MASH1 RNA 
expression.21 Dr. Turner’s laboratory a few years later dem-
onstrated that RA was not necessary for differentiation when 
used with MASH1. Transient transfection of MASH1 into P19 
cells fully resulted in neuronal differentiation,18 suggesting 
MASH1’s sufficiency as a neuronal activator. Many neuronal 
proteins seen expressed in P19 cells upon application of RA 
have been found in MASH1-transfected P19 cells.18 
Mouse knockouts of MASH1 have revealed its critical role 
as a regulatory gene in neuronal development and differen-
tiation. Mice that have a single knockout revealed weak but 
significant neurogenesis,22 whereas a full knockout of MASH1 
had massive neuron depletion.22 Cells that were normally 
destined to become neurons formed glial cells, indicative of 
MASH1’s regulatory role in neuronal fate determination.22 
Mice that have been bred with a null allele of the gene die 
at birth due to breathing and feeding defects.23 In regards 
to the breathing defect, previous studies have demonstrated 
loss of pulmonary neuroendocrine epithelium in MASH1 full 
knockout mice.24 MASH1-null mice completely lack neu-
ronal olfactory epithelium (which could describe the feeding 
defect).23 Perhaps the most important effect of the null mutant 
is that the sympathetic, parasympathetic, and enteric ganglia 
are severely affected in these animals.23 The massive lack of 
neuronal generation with a MASH1 null mutant has revealed 
its necessity to induce neuronal differentiation (and retinal 
differentiation25). 
Electrophysiological properties have also been observed in 
neurons transfected with MASH1.16 With MASH1 acting as 
the sole transcriptional activator in differentiating embryonic 
cells into neuronal cells, MASH1 has been suggested to be 
sufficient in conferring a neuronal fate on uncommitted mam-
malian cells.18 Without the need of RA and cell aggregation to 
induce neuronal differentiation, the generation of neurons via 
bHLH transfection has opened up new avenues in studying 
molecular neurogenesis.
The major benefit of MASH1-induced neuronal differen-
tiation in mouse P19 is its ability to produce neurons void of 
glial cells, which are present when induced with RA. In study-
ing specifically neurogenesis and/or molecular properties of 
neurons, MASH1 is especially helpful. The absence of glial-
specific proteins in MASH1-transfected P19 cells18 ensures the 
sole presence of developing neurons in vitro. 
MASH1 transfection studies in embryonic stem cells
MASH1 has in recent years become a popular and pow-
erful transcription factor for embryonic stem cell research. 
MASH1-transfected embryonic stem cells (ES) have been 
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shown to express high levels of Nestin mRNA from RT-PCR 
studies.26 Nestin is a type VI interfilament protein that is 
expressed in nerve cells. Presence of Nestin typically impli-
cates the radial growth of an axon. These MASH1-transfected 
ES cells also began to differentiate much earlier than ES cells 
treated with retinoic acid, and differentiated into neurons at 
high efficiency.26 Also, MASH1 has recently been shown 
to promote autonomic neurogenesis from neural crest stem 
cells.27 The protein is expressed in the mouse ventral region, 
specifying GABAergic neurons.28
MASH1 as a neurogenic bHLH gene product, binds and 
forms a heterodimer with a bHLH-activating factor E47, and 
this complex activates gene expression by binding to the E 
box consesus sequence (CANNTG).28 It is known that proteins 
of the regulatory bHLH gene family Hes inhibit neuronal 
differentiation. Hes1 is a major bHLH repressor gene regu-
lated by Notch that represses MASH1 activity by binding 
directly to the promoter sequence.28 The Notch pathway as a 
whole inhibits neuronal differentiation, maintaining the neural 
stem cell state. Recently, it was discovered that a unique Hes 
protein called Hes6 supports MASH1 activity by inhibiting 
Hes1 activity.29, 30 The absence of Hes1 consequently results 
in Notch’s failure to inhibit differentiation. Hes6 promotes 
neurogenesis via MASH1 in a positive feedback loop.30 
Therapeutic approaches using MASH1 are being devel-
oped. In spinal cord injury (SCI), research has found that 
Nogo Receptor (NgR) plays a critical role for axon growth 
inhibition in vitro, and inhibition of axonal regeneration and 
plastic responses post-SCI. MASH1-transfected ES cells have 
recently been shown to produce spinal motoneuron precur-
sors not expressing NgR via immunoblotting.31 SCI model 
mice that were transplanted with MASH1-transfected ES cells 
received significantly higher scores on motor tests than control 
SCI mice. By four weeks post-transplantation, the scores 
indicated that the MASH1-ES transplanted mice had coordi-
nation between their hind and fore limbs.31 The MASH1-ES 
SCI mice also revealed electrophysiological tests results that 
nearly reached the level of a sham-operated normal mouse. 
These motorneuron precursors not only survived in vivo, but 
also inhibited scarring and gliogenesis at the SCI site. Nestin 
is a neural stem/immature neural cell marker, and its expres-
sion disappeared 4 weeks post-transplantation, suggesting that 
the graft placed into these mice matured in vivo. 
Amidst this exciting research with MASH1 inducing 
neuronal differentiation, it is particularly interesting then 
to note that there has yet to be a study concerned with the 
potential effects that depolarization, a trademark of nervous 
system functionality, may have on neuronal differentiation. 
Specifically, there does not seem to be any recent literature 
concerned with the effects of potassium on MASH1 or any 
bHLH transcription factors in either embryonic carcinoma 
or stem cell models. The possible role of depolarization in 
MASH1-induced neuronal differentiation has not been fully 
explored. Although no neuronal relationship has been estab-
lished, an outward-rectifying sensitive potassium current in 
P19 cells that differentiate into cardiomyocytes has already 
been recently identified.32 This paper tests the hypothesis that 
depolarization increases neuronal differentiation of MASH1-
induced P19 cells in culture. Using P19 cells transiently trans-
fected with a P19 expression vector, the studies described here 
characterized the differentiation of P19 cells in the presence 
and absence of elevated potassium chloride, which depolarizes 
neurons by opening voltage sensitive potassium channels. In 
addition, we also determined whether elevation of intracellular 
calcium had any effect on the differentiation of the P19 cells 
using the calcium ionphore, ionomycin.
Methods
P19 Cell Line Growth/Passage. The complete growth media 
solution (αMEM (Gibco)) contained 10% of a 3:1 calf serum: 
fetal calf serum mixture and penicillin-streptomycin. P19 cells 
were continuously passaged in 100 x 20mm tissue culture 
plates containing 10mL complete αMEM, and maintained in a 
37°C incubator at 5% CO2. Cells were passed before conflu-
ency using trypsin and diluted 1:10 before plating every two 
days.
Transfection. Plates of P19 cells at 40-50% confluency were 
transfected with a mixture reagent of: 1.5mL αMEM, 81μL 
Mirus Bio Trans-IT®-LT1 lipid transfecting reagent, and 27μg 
of total DNA containing a mixture of US2MASH1 (18μg), 
US2GFP (6μg), and US2puro (3μg). Transfection efficiency 
was determined by scoring green GFP fluorescence on a 
Nikon *X70 fluorescence microscope.
Puromycin Selection/Cell Dilution. Transfected cells were 
diluted 1:10 for KCl experiments and 1:30 for ionomycin 
experiments to avoid cells from overcrowding and layering in 
the 24-well plate. Between 24-48 hours after transfection, the 
P19 plates were detached with trypsin, and re-suspended into 
10mL αMEM. The 10mL cell mixture was then transferred 
into a 50mL tube containing 28mL αMEM and mixed via 
pipetting. 24mL of that mixture was removed, and the remain-
ing 14mL mixture received 24mL αMEM and mixed to make 
a 1:10 P19 mixture. This process was repeated once more to 
make a 1:30 P19 cell dilution. 24mL of 1:10 P19 and 1:30 P19 
were separately transferred to its own 50mL tube containing 
24mL αMEM and 12μL puromycin (desired a 5μg/μL concen-
tration). Tubes were mixed via pipetting. 2mL of the 48mL 
mixture was then placed into each well of a laminin-coated 
24-well culture plate. Cells were exposed to the puromycin 
for 12 hours in the 37°C incubator, then removed and replaced 
with 1mL αMEM per well.
24-Well Culture Plate Setup. KCl and ionomycin treatments 
were performed on the 1:10/1:30 transfected P19 cells at 
48, 72, 96, and 120 hours since transfection. Each row (time 
point) had two control wells, and four experimental wells (i.e. 
20mM and 56mM KCl each had two wells per row).
KCl Addition. The 20mM (10μL) and 56mM (28μL) KCl-
αMEM solutions (KCL stock is 2 mg/ml) were administered 
at 48, 72, 96, and 120 hours since transfection. Media and 
KCl-αMEM were replaced every 24 hours. It is important to 
note that “96” KCl wells received KCl-αMEM every 24 hours, 
totaling 4 days’ worth of KCl exposure. The “72” treated cells 
received 3 days’ worth, “48” 2 day’s worth, and “24” 1 day’s 
worth.   
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Ionomycin Addition. For the ionomycin treatment, 0.8μL 
ionomycin (1mg/mL) in 400 αMEM mimicked a 1:500 one-
time ionomycin treatment. 4.0μL ionomycin in 400 αMEM 
mimicked a 1:100 one-time treatment. Experimental wells 
were exposed to ionomycin for one hour in the 37°C incuba-
tor, and then removed. Concentration and exposure time was 
chosen to avoid conditions that would promote apoptosis (i.e. 
1mM ionomycin exposure for four hours). All wells received 
1mL αMEM prior to overnight growth in the incubator.
Culture Plate Fixing/Staining. Cell plates were fixed in 4% 
formaldehyde solution (diluted from 37% formaldehyde with 
sterile 1X PBS) at 144 hours after transfection, and were 
subsequently stained with 1:5000 αTUJ1 (primary antibody), 
and 1:2000 Alexa Fluor 546 (secondary antibody) at room 
temperature. Fixed samples were placed in a 20°C room when 
not being stained or having pictures taken.
Photomicrography. All pictures of experiments were taken 
under the fluorescent microscope using bright field, green 
light (GFP expression) and red light (TUJ1 expression). 
Random sampling of GFP-expressing cells was taken at every 
time point and variable concentration/control, followed by its 
corresponding TUJ1 picture. KCl: One experiment counting 
90-cell samples (“KCl90”) was counted and pictured for the 
KCl experiments.Ionomycin: One experiment entitled “Ca30 
(Fig. 2)” counting 30-cell samples per time and concentration 
was counted and provided.
Counting. Cell counting of the pictures was manually per-
formed using images for GFP and TUJ1 expression. For all 
experiments excluding the JKCl series, five or six GFP cells 
were included in each picture and then compared to its cor-
responding TUJ1 picture. If there were more than five/six 
GFP cells observed in one picture, five of them were chosen at 
random prior to comparison to the TUJ1 picture.
Statistical Analysis. Statistical significance was measured 
by Microsoft Excel® two-sample t-tests assuming unequal 
variances because sample numbers differed for various condi-
tions. Significance was determined if the two-tailed p < 0.05. 
In the graphs, one and two asterisks were marked to compare 
between control and KCl concentrations for each time point. 
Asterisks greater than two in number were used to denote 
significance between different time points of the same KCl 
concentration.
Results
Time-dependent KCl-induced depolarization increases 
MASH1-dependent differentiation
P19 mouse embryo cells were transfected with MASH1 
from the US2 plasmid instead of RA, since the formation of 
glial cells would complicate the counting process (described 
in Methods). The cell cultures were diluted to 1:10 or 1:30 
to minimize cell layering and overlapping (which would 
complicate the picture taking and cell counting processes). 
Cells were cultured in a 24-well plate to observe progres-
sion of depolarization-induced differentiation over the span 
of 96 hours. All neurons in culture were identified immuno-
histochemically by TUJ1, a monoclonal antibody that stains 
against the neuronal class III β-tubulin. 
KCl was initially administered at 48 hours after trans-
fection and was replenished every 24 hours 4 times (i.e. 
48, 72, 96, 120 hours since transfection). It is important to 
note that with this setup, the “96” KCl wells were exposed 
to 20mM/56mM KCl the longest (96 hours’ worth of KCl 
exposure), and “24” hour KCl wells received  the shortest (24 
hours’ worth of KCl exposure).
Preliminary experiments presented a problem in determin-
ing statistical significance, which was attributed to the dispar-
ity in the number of cells counted per picture at different KCl 
concentrations. Instead of counting a maximum of 5 cells per 
picture to provide consistency in cell count for all pictures, 
some pictures were counted as high as 10 cells and others as 
low as 2. The 0mM cells were the most difficult of the three 
concentrations to find and many more picture sets were taken 
compared to the 20mM and 56mM concentrations. 
Having an uneven distribution of cell counts per field ap-
peared to have an effect on the two-sample t-test assuming 
unequal variances. Many p-values from the two-sample t-test 
were either 0.05 or close to 0.05, but could not be considered 
significant. It was strange to see that a large percentage differ-
ence in cell count (i.e. Supplement – JKCl Fig. 3: 96H 0mM 
and 56mM) would not be statistically significant. It was not 
unusual to find that if one or two more cells in that specific 
concentration and time point were TUJ1 positive, the effect 
would have been considered significant. 
Thus, “KCl90” was analyzed in a different manner. Based 
on observations from preliminary experiments, an evenly dis-
tributed number of cells per picture between varying KCl con-
centrations produced p-values much closer to 0.05 or at 0.05. 
Hence for the KCl90 data set, five or six GFP-expressing cells 
were counted per picture set, regardless of how many cells 
were present in a picture. By keeping the number of picture 
sets consistent for all concentrations, statistical significance 
was more accurately determined. The decision to increase the 
number of cells counted per time per concentration was done 
to ensure an adequate sample size for statistical analysis.
The KCl90 experiment (Figure 1) confirmed KCl’s facilita-
tive role in neuronal differentiation in a time-dependent man-
ner. While MASH1 consistently induced neuronal differentia-
tion in 89-90% of the P19 cells, the remaining 10-11% did not 
differentiate. After 48 hours of exposure to 20mM KCl, there 
was a significant decrease in non-TUJ1 expressing P19-GFP 
cells. Percentage of TUJ1-negative neurons decreased about 
6.5% with 20mM KCl exposure and 7.7% with 56mM KCl. 
After 72 hours of 20mM KCl exposure, about 7.7% of the 
original 10-11% of undifferentiated P19 had differentiated 
into neurons. With 96 hours of treatment, almost all of the P19 
cells were identified as neurons. Statistical significance was 
also measured between the “96” and “24” hour-long treatment 
of 20mM KCl, and the “96” or “72” treatment compared to 
the “24” hour treatment with the 56mM KCl, further implicat-
ing KCl’s time-dependent facilitative role.
Although not quantified, presence of neurons and axonal 
length was more pronounced in 20mM and 56mM KCl-
induced P19 than the 0mM P19 in a time-dependent manner 
(Figure 2).
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Ionomycin treatment of P19 cells does not increase neuronal 
differentiation
Calcium is a major second messenger that changes its 
concentration during depolarization. Calcium influx into the 
presynaptic terminal is critical to depolarization and release of 
neurotransmitter release to the postsynaptic terminal. Inves-
tigation of the effects of calcium-induced depolarization also 
needs to be observed. P19 cultures were set up identically to 
the KCl experiment prior to experimentation with a different 
set of experiments complementary to the initial set. Instead 
of manipulating the cultures with KCl, ionomycin which is a 
pore-inducing ionophore that allows only calcium ions to seep 
through the neuronal cell membrane, was used. The calcium 
influx into the cell is sufficient in inducing sodium influx, de-
polarization, and neurotransmitter exocytosis. This experiment 
served as a means of comparison to ensure the importance of 
voltage-gated potassium channel activity in depolarization-
induced differentiation in the P19 cells. 
Diluted concentrations of 1:100 (0.01mM) and 1:500 
(0.002 mM) from 1mM ionomycin were distributed to the ap-
propriate time well for sixty minutes into the P19 cells and in-
cubated at 37°C. Ionomycin concentrations and exposure time 
were chosen specifically to ensure pore opening of the P19 
cells, but to avoid apoptosis (i.e. 1mM exposure for 1 hour). 
30 cell-samples per time per concentration were selected for 
analysis, with even cell count per picture set.
Ionomycin experiments had a lower percentage of GFP-
positive P19 cells throughout the course of each experiment. 
The exact reason for lower GFP-expression was not deter-
mined. However, it was observed that after administering 
ionomycin to the P19 cells, many of these cells detached from 
the lamini-coated plate. This was observed particularly at the 
0.002mM ionomycin concentration. Hence, a smaller popu-
lation of cells per time per concentration was available for 
analysis. 
Treatment of P19 cells with the ionophore produced no 
significant increase or decrease in differentiation in Ca30. The 
percentage of GFP-expressing P19 cells exposed to ionomycin 
that did not express TUJ1 was fairly consistent, with small 
but not statistically significant decreases. Interestingly, more 
TUJ1 P19 cells were discovered with respect to the control 
when exposed to 0.002 mM ionomycin at the “72” hour wells. 
The mechanism responsible for this observation was not deter-
mined.
Discussion
Our findings suggest that KCl-induced depolarization may 
enhance differentiation of P19 cells transiently expressing 
MASH1, although improvements to the experimental protocol 
Figure 1: Exp "KCl90" - GFP-Expressing P19 not expressing TUJ1 (90 
Cells/Time/[M] KCl)
P19 cells were transfected and treated with 0, 20, or 56mM KCl as 
described in Materials and Methods. GFP fluorescence and TUJ1 stain-
ing were determined by fluorescence microscopy. Statistical significance 
measured at “96” (0mM and 20mM, 0mM and 56 mM), “72” (0mM 
and 20mM, 0mM and 56mM), and “48” (0mM and 56mM). 20mM KCl 
treatment produced significant results in P19-GFP cells after 72 hours of 
exposure to KCl. 56mM KCl treatment produced significant results after 
48 hours of exposure. Significance was also measured between differ-
ent time points of 20mM KCl treatment (“96” to “24”), and 56mM KCl 
treatment (“96” to “24”, “72” to “24”). 
Figure 2: KCl90 Picture Compilation 
P19 cells were transfected and treated with 0, 20, or 56 mM KCl as 
described in Materials and Methods. GFP fluorescence and TUJ1 stain-
ing were determined by fluorescence microscropy.Each row corresponds 
to KCl concentrations (Top-Down: 0, 20, 56 mM), and each green-red 
column set corresponds to time (Left-Right: 24, 48, 72, 96 hours). 
Pronounced GFP (green)/TUJ1(red) correlation can be readily observed 
especially in 20mM “72 (O-P)” and “96 (U-V)” hours, and 56mM “48 
(K-J)”, “72 (Q-R)”, and “96 (W-X)” hour-long treatments. 
Figure 3: Exp "Ca30" -GFP-Expressing P19 not expressing TUJ1 (30 
Cells/Time/[M] ionomycin)
P19 cells were transfected and treated with 0, 0.002, or 0.01 mM iono-
mycin as described in Materials and Methods. GFP fluorescence and 
TUJ1 staining was determined by fluorescence microscopy. Statistical 
significance was not observed at any time point treated with 0.002mM or 
0.01mM ionomycin for one hour.
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may have increased the statistical significance of the results 
obtained. For instance, there is concern that adding such high 
levels of KCl to the extracellular media could have undesir-
able effects on osmotic responses of the cells. The addition 
of 56mM NaCl solution to untransfected cells could serve as 
an important control in this respect. Theoretically, the NaCl 
would have produced the same osmotic effects as the 56mM 
KCl, but would have not had an effect on the voltage-gated 
potassium channels. This control was not tested. . With respect 
to the staining, we could have also measured Ca2+ activity via 
staining with Fura2 instead of TUJ1. This technique also was 
not tested on the KCl-affected P19 cells.
Nonetheless, the KCl90 experiment results suggest that 
membrane-bound voltage-gated potassium channels on P19 
cells facilitate MASH1-dependent neuronal differentiation. 
The ionomycin experiment results suggest that calcium influx 
into the cell is insufficient to facilitate depolarization, and that 
a molecular mechanism downstream of the voltage-gated po-
tassium channel may be responsible for the activity seen in the 
KCl experiments. However, further experiments are required 
to truly demonstrate that both KCl and ionomycin resulted 
in changes in intracellular concentration of potassium for the 
treated P19 cells.  If there is another channel downstream that 
the voltage-gated potassium channel works through, identifi-
cation of the channel and its relationship to the voltage-gated 
potassium channels is critical to better understanding depolar-
ization-induced differentiation.
Membrane depolarization has been long known to acti-
vate voltage-gated sodium and calcium channels. Neuronal 
physiological processes from action potentials (voltage-gated 
sodium) to synaptic transmission, local signaling and process-
ing, and gene expression (voltage-gated calcium) are depen-
dent upon these channels. 
 In regards to voltage-gated calcium channels, they are 
critical for calcium influx entry at the axon terminal for proper 
exocytosis of neurotransmitters into the synaptic cleft via the 
SNARE complex.34 The Cav2.1 channel has been shown to be 
the predominant pathway in rapid release of neurotransmitters 
such as glutamate, acetylcholine, and GABA.34 This channel 
has been coimmunoprecipitated with CamKII, a ubiquitously 
expressed protein kinase and one of the most important cal-
cium receptors in neurons. The kinase has been found to bind 
to the C-terminal domain of the Cav2.1 channel and to en-
hance its activity by slow inactivation and shifting the voltage 
dependence of inactivation positively.34 Regulation in situ in 
skeletal and cardiac muscle cells has been attributed to Cav1.1 
and Cav1.2 respectively.34
With the understanding that voltage-gated calcium chan-
nels are critical to neuron function, it is important in further 
researching potential candidate voltage-gated channels that act 
downstream of the membrane-bound voltage-gated potassium 
channel.
Three candidate genes currently may serve to mediate the 
effect of KCl in P19 cells. The mRNA expression of Cacna1h, 
a T-type calcium channel in P19 cells, has been shown to 
increase nine-fold within twenty-four hours since MASH1 
transfection, and ten-fold six days after transfection. T-type 
calcium channels are low-voltage-activated channels that con-
trol neuron excitability and responsiveness under physiologi-
cal conditions near resting states, and are widely expressed in 
various types of neurons.35 These channels have been suggest-
ed to be potential therapeutic targets in the nervous system.35
The two other candidates are genes that upregulate potas-
sium channels, Kcnkl3 and Kcnc4. These genes have also 
shown elevated mRNA expression in P19 cells once trans-
fected with MASH1. Within twenty-four hours of transfection, 
expression of Kcnkl3 has been shown to reach seventeen-fold. 
Elevated mRNA expression of these three genes has been 
observed in microarray analysis at Dr. Uhler’s laboratory.
Since the mRNA expression of these genes magnify greatly 
within only a span of twenty-four hours, it raises the question 
as to whether the potassium effect on P19 cells is actually 
time-dependent, or needs to be expressed as a specific time 
point. It would be imperative to also run the same KCl experi-
ment, but make the exposure of KCl equal between all the 
time points. Observations then must be made to see whether 
or not the length of axonal processes between the “96/72/48” 
and the “24” fields replicate the results observed in the KCl90 
experiment.
Any, all, or none of these three genes could be involved in 
P19 signal processing downstream of the KCl-induced depo-
larization. Verification of the gene’s activity downstream of 
depolarization could be determined by blocking or silencing 
the channel. Pre-treatment of conotoxin, a neurotoxic peptide 
that specifically blocks T-type calcium channels, onto P19 
cells followed by KCl treatment would determine Cacna1h’s 
role downstream of voltage-gated potassium channels. Gene 
silencing of each candidate via RNAi silencing technique 
(short-hair pin constructs ordered from Open BioSystems®) 
followed by KCl treatment is another method that could be 
used to evaluate each gene’s requirement for depolarization-
induced differentiation. 
Another avenue of experimental pursuit is observing the 
importance of KCl in forming and maintaining functional syn-
apses. Previous research has shown that PC12 (primary bovine 
chromaffin) cells depolarized with elevated K+ levels releases 
human growth hormone in similar proportions to endogenous 
catecholamine release.36 With potassium having been shown 
to mimic synaptic depolarization,36 and with the understanding 
that activation of calcium-sensitive potassium channels occurs 
at the synaptic level, it is pertinent to investigate the effect 
of KCl in P19-derived synaptic formation, functionality, and 
maintenance. This study has only observed the effect of KCl 
exposure on P19-derived neurons at maximum for four days, 
and the cells were stained with an antibody that detects neuron 
cytoskeletal proteins. Long-term effects of KCl on P19 cells 
(15-30 days) would better suggest its role(s) at the synaptic 
level.  
Studies of P19 embryonic carcinoma cells have signifi-
cantly advanced our understanding of neuronal development. 
Much research has yet to be done to better understand the 
molecular mechanisms underlying depolarization-facilitated 
neuronal cell differentiation. While the results of the current 
studies are not conclusive, the finding supports our original 
hypothesis that depolarization of P19 cells would enhance 
neuronal differentiation. Additional experiments in the future 
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to include other markers of neuronal differentiation such as 
synaptic proteins and electrophysiological measurements of 
synaptic transmission will be required to conclusively test 
our hypothesis. However, our findings do provide additional 
justification for more rigorously testing the role of depolariza-
tion in P19 neuronal differentiation. With this relationship 
established, new therapeutic strategies for neurodegenerative 
disorders can be discovered and developed.
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